SMC Rejects Sotatercept For Pulmonary Hypertension

Scotland’s medicines regulator has rejected sotatercept for PAH, citing insufficient cost-effectiveness evidence despite improved exercise capacity.
Medscape News UK

Source link : https://www.medscape.com/viewarticle/smc-rejects-sotatercept-pulmonary-hypertension-2026a100042g?src=rss

Author :

Publish date : 2026-02-09 17:08:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

SMC Rejects Sotatercept For Pulmonary Hypertension

Lindsey Vonn Breaks Leg in Downhill Crash at Winter Olympics, in Stable Condition

Gravitational wave signal proves Einstein was right about relativity

Related Posts

New CDC Messaging May Be Eroding Trust in Vaccines, Survey Finds

Why Can’t Europe Kick Its Antibiotic Habit?

Physician Groups Want Better Enforcement of No Surprises Act

Dr. Mike’s Guinness World Record; Aluminum Deodorant PSA; RN’s Surprise Afib

Defibrillation Testing Not Needed After S-ICD?

New AI Model Beats Doctors at Clinical Reasoning, Diagnosis

New CDC Messaging May Be Eroding Trust in Vaccines, Survey Finds

Why Can’t Europe Kick Its Antibiotic Habit?

Physician Groups Want Better Enforcement of No Surprises Act

Dr. Mike’s Guinness World Record; Aluminum Deodorant PSA; RN’s Surprise Afib

Defibrillation Testing Not Needed After S-ICD?

New AI Model Beats Doctors at Clinical Reasoning, Diagnosis

‘We felt we had to miscarry again to get the help we needed’

FDA Panel Gives Thumbs Down to Novel Strategy for Switching Breast Cancer Therapy

Categories

Archives